Issues for conducting meta-analyses in COVID-19. Commentary on "Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis''.
作者信息
Etoom Mohammad, Alwardat Sofian, Alwardat Mohammad
机构信息
Physical Therapy Department, Isra University, Amman, Jordan.
PhD School of Microbiology, Immunology, Infectious Diseases, Transplantation and Related Disease, University of Rome Tor Vergata, Rome, Italy; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
出版信息
J Clin Virol. 2020 Jul;128:104389. doi: 10.1016/j.jcv.2020.104389. Epub 2020 Apr 28.
Abstract
摘要
相似文献
1
Issues for conducting meta-analyses in COVID-19. Commentary on "Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis''.新型冠状病毒肺炎（COVID-19）荟萃分析中的问题。对《2019年冠状病毒病（COVID-19）的患病率和严重程度：一项系统评价和荟萃分析》的评论
J Clin Virol. 2020 Jul;128:104389. doi: 10.1016/j.jcv.2020.104389. Epub 2020 Apr 28.
2
Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.饮酒与新冠病毒疾病严重程度无关：一项系统综述与荟萃分析
J Infect. 2020 Aug;81(2):e126-e127. doi: 10.1016/j.jinf.2020.05.042. Epub 2020 May 28.
3
Developing guidelines for COVID-19 management: A moving target. An invited commentary on "Evidence based management guideline for the COVID-19 pandemic - Review article".制定COVID-19管理指南：一个不断变化的目标。对《COVID-19大流行的循证管理指南——综述文章》的特邀评论。
Int J Surg. 2020 Jun;78:42. doi: 10.1016/j.ijsu.2020.04.030. Epub 2020 Apr 21.
4
Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".关于《新冠病毒感染患者嗅觉和味觉功能障碍的患病率：系统评价与荟萃分析》的评论
Otolaryngol Head Neck Surg. 2020 Oct;163(4):852. doi: 10.1177/0194599820934761. Epub 2020 Jun 9.
5
Immunomodulation for the management of corona virus disease (COVID-19).用于冠状病毒病（COVID-19）管理的免疫调节
Transfus Apher Sci. 2020 Aug;59(4):102856. doi: 10.1016/j.transci.2020.102856. Epub 2020 Jun 27.
6
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
7
Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.新型冠状病毒肺炎（COVID-19）表现为结膜炎：大流行期间非典型高风险情况
Cont Lens Anterior Eye. 2020 Jun;43(3):211-212. doi: 10.1016/j.clae.2020.04.010. Epub 2020 Apr 27.
8
Adding to the debate on the influence of temperature on corona virus disease (COVID-19): the case of Brazil.关于温度对冠状病毒病（COVID-19）影响的争论再添一例：巴西的情况。
Public Health. 2020 Oct;187:74-76. doi: 10.1016/j.puhe.2020.07.040. Epub 2020 Aug 14.
9
Corona Virus Disease 2019, a growing threat to children?2019 年冠状病毒病，对儿童的威胁日益增加？
J Infect. 2020 Jun;80(6):671-693. doi: 10.1016/j.jinf.2020.02.024. Epub 2020 Mar 3.
10
Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".关于《重症及死亡COVID-19病例的危险因素：系统文献综述与荟萃分析》的临床及概念性评论
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.011. Epub 2020 May 11.
引用本文的文献
1
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.2019冠状病毒病的转归与糖尿病：一项多中心前瞻性队列综合研究
Microorganisms. 2023 May 27;11(6):1416. doi: 10.3390/microorganisms11061416.
2
Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment.氯喹、羟氯喹和绿茶儿茶素对严重急性呼吸综合征冠状病毒2型主要蛋白酶（Mpro）和3C样蛋白酶的新型抗病毒作用用于治疗新型冠状病毒肺炎。
Clin Nutr Open Sci. 2022 Apr;42:62-72. doi: 10.1016/j.nutos.2021.12.004. Epub 2022 Jan 28.
3
COVID-19: Where is the treatment?新冠病毒肺炎：治疗方法在哪里？
World J Clin Oncol. 2021 May 24;12(5):309-322. doi: 10.5306/wjco.v12.i5.309.
本文引用的文献
1
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.新型冠状病毒病 2019（COVID-19）的患病率和严重程度：系统评价和荟萃分析。
J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14.
Zotero 插件